NYSE:PFE
Pfizer Stock News
$28.16
+0.350 (+1.26%)
At Close: May 06, 2024
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Tuesday, 19'th Mar 2024
Pfizer (PFE) closed at $27.63 in the latest trading session, marking a -0.32% move from the prior day.
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
05:07pm, Tuesday, 19'th Mar 2024
Dividend stocks are looking more and more attractive these days. Especially when you consider a given share of some companies can be prohibitively expensive.
Pfizer (PFE) to Decrease Stake in Haleon From 32% to 24%
12:11pm, Tuesday, 19'th Mar 2024
Pfizer (PFE) plans to sell some shares of consumer healthcare firm Haleon (HLN), which it owns, to bring down its stake from 32% to 24%.
Pfizer upsizes Haleon stake sale
04:14am, Tuesday, 19'th Mar 2024
Haleon PLC (LSE:HLN, NYSE:HLN) said Pfizer Inc (NYSE:PFE, ETR:PFE) had sold a larger than expected amount of its shares overnight, scooping roughly £2.4 billion compared to the £2 billion expected
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move
05:49am, Monday, 18'th Mar 2024
Pfizer faces challenges including declining COVID-19 sales and a looming patent cliff. However, the company's growth prospects look good.
Pfizer to sell down stake in Haleon
03:27am, Monday, 18'th Mar 2024
Pfizer Inc (NYSE:PFE, ETR:PFE) has confirmed it will sell a large chunk of its stake in Haleon PLC (LSE:HLN, NYSE:HLN), raising over £2 billion (US$2.55bn). Haleon, a former consumer health joint ve
Consumer healthcare giant Haleon says Pfizer to cut stake to 24%
03:09am, Monday, 18'th Mar 2024
Consumer healthcare giant Haleon said on Monday that Pfizer will sell about 630 million of its shares in the company, reducing the US drugmaker's stake to about 24%.
Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
09:16pm, Sunday, 17'th Mar 2024
Pfizer's stock has dropped over the last year+ due to declines in revenue and profit from Covid-related products. The company's non-Covid products have shown growth, indicating potential for continued
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
05:51am, Saturday, 16'th Mar 2024
Alibaba should benefit from a strong AI tailwind. Enterprise Products Partners has a key advantage in delivering exceptional total returns.
This overlooked corner of women's health could be a $350 billion market opportunity
02:33pm, Friday, 15'th Mar 2024
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
3 Precision Medicine Stocks That Could Benefit From the Industry's Rise
12:39pm, Friday, 15'th Mar 2024
Now might be a great time for investors to consider investing in precision medicine stocks. For those who don't know, precision medicine is an approach to disease treatment and prevention that tailors
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 15'th Mar 2024
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Is Pfizer Stock a Millionaire Maker?
09:30am, Friday, 15'th Mar 2024
Pfizer has been investing heavily in growth, with several acquisitions in recent years. The company plans to add $25 billion in revenue by the end of the decade.
30,000 Followers Special - Here's How I Would Invest $30,000 In Today's Market
07:00am, Friday, 15'th Mar 2024
Achieving 30,000 followers on Seeking Alpha was unexpected, and I want to thank everyone for their trust and support! In light of rising inflation and market uncertainty, I advocate for long-term inve
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
05:50am, Friday, 15'th Mar 2024
Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.